Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$29.97 - $47.42 $203,796 - $322,456
6,800 Added 95.77%
13,900 $516,000
Q2 2024

Aug 14, 2024

SELL
$38.07 - $52.25 $894,645 - $1.23 Million
-23,500 Reduced 76.8%
7,100 $338,000
Q1 2024

May 15, 2024

SELL
$27.67 - $39.61 $368,011 - $526,813
-13,300 Reduced 30.3%
30,600 $1.17 Million
Q4 2023

Feb 14, 2024

BUY
$30.6 - $43.78 $563,040 - $805,552
18,400 Added 72.16%
43,900 $1.37 Million
Q3 2023

Nov 14, 2023

BUY
$39.39 - $58.12 $716,898 - $1.06 Million
18,200 Added 249.32%
25,500 $1.02 Million
Q2 2023

Aug 14, 2023

BUY
$50.45 - $72.82 $95,855 - $138,358
1,900 Added 35.19%
7,300 $383,000
Q1 2023

May 15, 2023

BUY
$51.25 - $79.34 $276,750 - $428,436
5,400 New
5,400 $345,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.35B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.